2023
Low‐Field Portable Magnetic Resonance Imaging for Post‐Thrombectomy Assessment of Ongoing Brain Injury
Sujijantarat N, Koo A, Jambor I, Malhotra A, Mazurek M, Parasuram N, Yadlapalli V, Chavva I, Lalwani D, Zabinska J, Roy J, Antonios J, Elsamadicy A, Renedo D, Hebert R, Schindler J, Gilmore E, Sansing L, de Havenon A, Olexa M, Schiff S, Iglesias J, Rosen M, Kimberly W, Petersen N, Sheth K, Matouk C. Low‐Field Portable Magnetic Resonance Imaging for Post‐Thrombectomy Assessment of Ongoing Brain Injury. Stroke Vascular And Interventional Neurology 2023, 3 DOI: 10.1161/svin.123.000921.Peer-Reviewed Original ResearchMechanical thrombectomyInterventional radiology suiteMagnetic resonance imagingRadiology suiteConventional MRIResonance imagingCerebral Infarction scoreOngoing brain injuryLarge vessel occlusionInfarct burdenRevascularization timeInfarct volumeClinical characteristicsInfarct progressionAdverse eventsIschemic changesMethods PatientsMedian timeBedside evaluationBrain injuryTimely imagingResults TwentyPatientsSubsequent imagingProcedural details
2017
Leptomeningeal disease: current diagnostic and therapeutic strategies
Nayar G, Ejikeme T, Chongsathidkiet P, Elsamadicy AA, Blackwell KL, Clarke JM, Lad SP, Fecci PE. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget 2017, 5: 73312-73328. PMID: 29069871, PMCID: PMC5641214, DOI: 10.18632/oncotarget.20272.Peer-Reviewed Original ResearchLeptomeningeal diseaseT1-weighted magnetic resonance imagingCerebrospinal fluid cytologyLate-stage complicationsNovel therapeutic interventionsMagnetic resonance imagingLeptomeningeal spreadMedian survivalNeurological deficitsPrimary malignancyObstructive hydrocephalusSystemic diseaseCancer patientsLung cancerTreatment modalitiesFluid cytologyBreast cancerRadiation therapyTherapeutic strategiesTherapeutic interventionsMalignant cellsResonance imagingYounger ageEarly detectionDisease